Abbott Laboratories’s recently made public that its EVP AND GROUP PRESIDENT Earnhardt Lisa D unloaded Company’s shares for reported $12.2 million on Mar 06 ’25. In the deal valued at $133.82 per share,91,167 shares were sold. As a result of this transaction, Earnhardt Lisa D now holds 71,928 shares worth roughly $9.18 million.
Then, Earnhardt Lisa D sold 200 shares, generating $27,329 in total proceeds. Upon selling the shares at $136.65, the EVP AND GROUP PRESIDENT now owns 71,928 shares.
Before that, Lisa D. Earnhardt bought 200 shares. Abbott Laboratories shares valued at $27,329 were divested by the Officer at a price of $136.65 per share.
Oppenheimer initiated its Abbott Laboratories [ABT] rating to an Outperform in a research note published on October 08, 2024; the price target was $130. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who began to cover the stock in mid September with a ‘”an Overweight”‘ rating. Edward Jones also remained covering ABT and has decreased its forecast on July 30, 2024 with a “Hold” recommendation from previously “Buy” rating. Goldman started covering the stock on May 30, 2024. It rated ABT as “a Buy”.
Price Performance Review of ABT
On Monday, Abbott Laboratories [NYSE:ABT] saw its stock jump 0.73% to $127.64. Over the last five days, the stock has lost -7.08%. Abbott Laboratories shares have risen nearly 12.85% since the year began. Nevertheless, the stocks have risen 6.23% over the past one year. While a 52-week high of $141.23 was reached on 03/04/25, a 52-week low of $99.71 was recorded on 01/15/25. SMA at 50 days reached $127.10, while 200 days put it at $115.33.
Levels Of Support And Resistance For ABT Stock
The 24-hour chart illustrates a support level at 126.60, which if violated will result in even more drops to 125.57. On the upside, there is a resistance level at 128.27. A further resistance level may holdings at 128.91. The Relative Strength Index (RSI) on the 14-day chart is 40.60, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -6.36, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 81.23%. Stochastics %K at 13.09% indicates the stock is a buying.
How much short interest is there in Abbott Laboratories?
A steep rise in short interest was recorded in Abbott Laboratories stocks on 2025-02-28, growing by 4.69 million shares to a total of 22.93 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 18.24 million shares. There was a rise of 20.46%, which implies that there is a positive sentiment for the stock.
